These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7803730)

  • 21. The significance of changing trends in prostate cancer incidence and mortality.
    Krongrad A; Lai S; Vidal EM
    Semin Urol Oncol; 1998 Feb; 16(1):30-4. PubMed ID: 9508080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of prostate cancer part I: descriptive epidemiology.
    Brawley OW; Knopf K; Merrill R
    Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncertainty after treatment for prostate cancer: definition, assessment, and management.
    Yu Ko WF; Degner LF
    Clin J Oncol Nurs; 2008 Oct; 12(5):749-55. PubMed ID: 18842531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
    Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
    Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter?
    Polasek O; Kolcic I; Voncina L; Strnad M; Vuletic S; Kern J
    Rural Remote Health; 2007; 7(3):749. PubMed ID: 17900222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of quality of life in men with prostate cancer.
    Albaugh J; Hacker ED
    Clin J Oncol Nurs; 2008 Feb; 12(1):81-6. PubMed ID: 18258577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer.
    Balducci L; Pow-Sang J; Friedland J; Diaz JI
    Clin Geriatr Med; 1997 May; 13(2):283-306. PubMed ID: 9115452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
    J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer.
    Penson DF; Chan JM;
    J Urol; 2007 Jun; 177(6):2020-9. PubMed ID: 17509282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.
    Mullan RJ; Jacobsen SJ; Bergstralh EJ; Slezak JM; Tindall DJ; Lieber MM; Roberts RO
    BJU Int; 2005 May; 95(7):951-5. PubMed ID: 15839911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis, management and screening of early localised prostate cancer.
    Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
    Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostate cancer screening].
    Villers A; Rébillard X; Soulié M; Davin JL; Coloby P; Moreau JL; Mejean A; Irani J; Coulange C; Mangin P;
    Prog Urol; 2003 Apr; 13(2):209-14. PubMed ID: 12765053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regular PSA screens undervalued, underutilized in prostate cancer detection.
    Healthc Demand Dis Manag; 2000 May; 6(5):70-2, 65. PubMed ID: 11383016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass screening for prostate cancer in Korea: a population based study.
    Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
    J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
    Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
    Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
    Gerard MJ; Frank-Stromborg M
    Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.